aramchol

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

non-alcoholic fatty liver disease (NASH)

Mechanism of action

modulate stearoyl-CoA desaturase-1 (SCD1)
reduces liver fat, improves liver histopathology

More general terms

References

↑ Walker M Novel SCD1 Modulator Reduced Liver Fat in NASH Patients - Dose-response pattern seen for aramchol in phase IIb ARREST trial. MedPage Today. Nov 14, 2018 https://www.medpagetoday.com/meetingcoverage/aasld/76347

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=18738120

Retrieved from "https://aaushi.info/w/index.php?title=A55528&oldid=1027402"

↑ Back to top